FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person
*
|
2. Issuer Name
and
Ticker or Trading Symbol
Celanese CORP [ CE ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __ X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
C/O THE BLACKSTONE GROUP, 345 PARK AVENUE |
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
NEW YORK, NY 10154 |
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person _ X _ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security
(Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Series A common stock, par value $0.0001 per share | 3/9/2005 | J (1) | 4305679 | A | (1) | 4305679 | I | See Footnotes (1) (2) (3) (4) (5) (6) (7) | ||
Series A common stock, par value $0.0001 per share | 3/9/2005 | J (1) | 298611 | A | (1) | 298611 | I | See Footnotes (1) (2) (3) (4) (5) (6) (7) | ||
Series A common stock, par value $0.0001 per share | 3/9/2005 | J (1) | 2340976 | A | (1) | 2340976 | I | See Footnotes (1) (2) (3) (4) (5) (6) (7) |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Remarks:
(See signatures of other Reporting Persons attached as Exhibit 99.1) |
Signatures
|
||
/s/ Robert L. Friedman, Director of Blackstone LR Associates (Cayman) IV Ltd. | 3/9/2005 | |
** Signature of Reporting Person |
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
Exhibit 99.1
Joint Filer Information
Blackstone Chemical Coinvest Partners (Cayman) L.P.
By: Blackstone Management Associates (Cayman) IV L.P., its general partner
By: Blackstone LR Associates (Cayman) IV Ltd., its general partner
By: /s/ Robert L. Friedman ------------------------- Name: Robert L. Friedman Title: Director |